It has been shown that niclosamide effectively limits different types of cancer growth both in vitro and in vivo by triggering apoptosis and oxidative stress or by inhibiting several important signaling pathways including Wnt/β-catenin [23–25], mTOR [26], NFκB [19], and STAT3 [14,27]. The gene discussed is NFKB1; the disease is cancer.